Ariose Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Ariose Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-51,009	Closed	-$8.46M	–	50
2019 Q4	$8.46M	Buy	+51,009	New	+$8.48M	12.36%	4
2018 Q2	–	Sell	-92,080	Closed	-$15.5M	–	11
2018 Q1	$15.5M	Buy	+92,080	New	+$12.5M	7.61%	5
2017 Q4	–	Sell	-52,600	Closed	-$5.44M	–	15
2017 Q3	$5.44M	Sell	52,600 -141,009	-73%	-$10.5M	1.46%	10
2017 Q2	$8.71M	Sell	193,609 -5,000	-3%	-$197K	2.86%	6
2017 Q1	$7.27M	Buy	198,609 +160,010	+415%	+$5.83M	3.58%	5
2016 Q4	$1.17M	Hold	38,599	–	–	0.38%	11
2016 Q3	$1.26M	Buy	+38,599	New	+$1.12M	0.34%	14

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ariose Capital Management's ONC Position: Q1 2020 in Review

Ariose Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 51,009 shares — an estimated $8.46M sold.

Ariose Capital Management first reported a position in ONC in Q3 2016 and held it in 7 quarters. The position peaked at $15.5M in Q1 2018. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

Ariose Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
Ariose Capital Management sold 51,009 BeOne Medicines Ltd shares in Q1 2020, an estimated $8.46M.
Ariose Capital Management first reported a position in BeOne Medicines Ltd in Q3 2016 and held it in 7 quarters.
Ariose Capital Management's BeOne Medicines Ltd position peaked at $15.5M in Q1 2018.
215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Ariose Capital Management's 13F filing for Q1 2020, filed 8 May 2020.